BioCorRx Inc. (BICX) › Cash & EquivalentsBioCorRx Inc. (BICX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $27.9K2010: $7.1K2011: $1.7K2012: $6.0K2013: $108.6K2014: $53.1K2015: $220.1K2018: $279.8K2019: $2.65M2020: $592.1K$592.1K2009Cash & Equivalents (USD)2020Fiscal YearCash & EquivalentsChange YoY2020$592.1K-77.6%2019$2.65M+845.7%2018$279.8K—2015$220.1K+314.3%2014$53.1K-51.1%2013$108.6K+1708.8%2012$6.0K+262.2%2011$1.7K-76.8%2010$7.1K-74.5%2009$27.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share